CTOs on the Move

Defense Health Agency

www.health.mildha

 
The DHA is a joint, integrated Combat Support Agency that enables the Army, Navy, and Air Force medical services to provide a medically ready force and ready medical force to Combatant Commands in both peacetime and wartime. The DHA supports the delivery of integrated, affordable, and high quality health services to 9.5 million Military Health System beneficiaries and is responsible for driving greater integration of clinical and business processes across the MHS. The DHA oversees the delivery of health care services like the TRICARE Health Plan, pharmacy, public health, and health information technology. DHA carries out these operations using a ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.health.mildha
  • 7700 Arlington Boulevard Suite 5101
    Falls Church, VA USA 22042
  • Phone: 888.647.6676

Executives

Name Title Contact Details
Lisa Belter
Chief Technology Officer Profile

Similar Companies

The Primary Health Network

The Primary Health Network is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sharon, PA. To find more information about The Primary Health Network, please visit www.primary-health.net

Sunquest Information Systems

Sunquest Information Systems, Inc. provides healthcare information systems to large and mid-sized hospitals, clinics and other facilities, including integrated delivery networks comprised of multi-entity, multi-site healthcare organizations.

Mirth Corporation

Mirth Corporation is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JJ WIld

JJ WIld is a Canton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.